262 related articles for article (PubMed ID: 24004449)
21. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Nestal de Moraes G; Delbue D; Silva KL; Robaina MC; Khongkow P; Gomes AR; Zona S; Crocamo S; Mencalha AL; Magalhães LM; Lam EW; Maia RC
Cell Signal; 2015 Dec; 27(12):2496-505. PubMed ID: 26404623
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW
Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Her-2 upregulates FoxM1 in gastric cancer.
Qi W; Li X; Zhang Y; Yao R; Qiu W; Tang D; Liang J
Int J Mol Med; 2014 Jun; 33(6):1531-8. PubMed ID: 24715000
[TBL] [Abstract][Full Text] [Related]
26. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.
Zeng J; Wang L; Li Q; Li W; Björkholm M; Jia J; Xu D
J Pathol; 2009 Aug; 218(4):419-27. PubMed ID: 19235838
[TBL] [Abstract][Full Text] [Related]
27. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
Jiang L; Wang P; Chen H
Ups J Med Sci; 2014 Nov; 119(4):324-32. PubMed ID: 25231007
[TBL] [Abstract][Full Text] [Related]
29. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
Ge N; Jiang YY; Pan ZP; Wan J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
[TBL] [Abstract][Full Text] [Related]
32. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
[TBL] [Abstract][Full Text] [Related]
35. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
36. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
[TBL] [Abstract][Full Text] [Related]
37. A Positive Feedback Loop of lncRNA-
Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
[No Abstract] [Full Text] [Related]
38. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
[TBL] [Abstract][Full Text] [Related]
39. 3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.
Ahmad A; Ali S; Wang Z; Ali AS; Sethi S; Sakr WA; Raz A; Rahman KM
Int J Cancer; 2011 Oct; 129(7):1781-91. PubMed ID: 21154750
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
Wang JY; Jia XH; Xing HY; Li YJ; Fan WW; Li N; Xie SY
Mol Med Rep; 2015 Jul; 12(1):1457-64. PubMed ID: 25760224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]